Clinical Trials Sponsored by Quantum Genomics SA

Total 11 results

Quantum Genomics SA

Completed

Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins (NEW-HOPE)

Hypertension

United States
Quantum Genomics SA

Completed

Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo

Essential Hypertension

France
Quantum Genomics SA

Completed

Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction (QUORUM)

Myocardial Infarction

Poland, Germany, France, Hungary, Slovakia, Spain, United Kingdom
Quantum Genomics SA

Terminated

QUantum Genomics Incremental Dosing in Heart Failure - QUID-HF (QUID-HF)

Heart Failure

France, Germany, Netherlands, United Kingdom, Hungary, Norway, Czechia, Poland
Quantum Genomics SA

Completed

Study of the Product QGC001 as a Single Dose and Multiple Doses Administered Orally to Healthy Adult Subjects

Essential Hypertension

France
Quantum Genomics SA

Completed

Firibastat in Treatment-resistant Hypertension (FRESH)

Hypertension

United States, Czechia, France, Germany, Poland, Spain
Quantum Genomics SA

Completed

Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension (2QG1)

Essential Hypertension

France
Quantum Genomics SA
Quotient Sciences

Completed

Evaluation of the PK Profile of Firibastat Following Administration of Firibastat Prototype Tablet Formulations

Healthy Males

United Kingdom
Quantum Genomics SA
Eurofins Optimed

Completed

Pharmacokinetics in End Stage Renal Disease Patients

Renal Failure | Healthy Volunteers

France
Quantum Genomics SA
PRA Health Sciences

Terminated

Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH) (REFRESH)

Hypertension (HTN)

United States, Canada
University of Lisbon
Cardiovascular Centre of Universidade de Lisboa (CCUL); Faculty of Medicine... and other collaborators

Completed

VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection (VITACOV)

COVID-19

Portugal

Clinical Trials Sponsored by Quantum Genomics SA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations